QUOTE AND NEWS
StreetInsider.com  Dec 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Timberline+Resources+%28TLR%29+Prices+Offering+at+20+Cents+Per+Share/7962641.html for the full story.
StreetInsider.com  Dec 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Timberline+Resources+%28TLR%29+Announces+Common+Stock+Offering/7959300.html for the full story.
StreetInsider.com  Dec 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Timberline+Resources+Corp.+%28TLR%29+Reports+Q4+Loss+of+%240.04/7948844.html for the full story.
StreetInsider.com  Oct 30  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Idera+Pharma+%28IDRA%29+Updates+on+Positive+TLR%2C+IL-1+Beta+Inhibition+in+Preclinicals/7826974.html for the full story.
Benzinga  Sep 17  Comment 
Timberline Resources Corporation (NYSE: TLR) announced today that its joint venture partner, Highland Mining, LLC ("Highland") has sold its 50-percent interest in Butte Highlands JV, LLC ("BHJV") to Montana State Gold Company, LLC ("MSGC"), a...
Benzinga  Jun 21  Comment 
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced results from preclinical studies evaluating the mechanism of action of IMO-8400, a selective inhibitor of Toll-like Receptors (TLRs) 7, 8, and 9. The data were presented on Wednesday, June...
StreetInsider.com  May 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Timberline+Resources+%28TLR%29+Files+%2430M+Common%2C+Warrants+Shelf/7433166.html for the full story.
FierceBiotech  May 3  Comment 
Cambridge, MA-based Idera Pharmaceuticals lost its big partner on toll-like receptor drugs when Merck KGaA backed out of its $421 million deal last year. This morning the biotech highlighted just how problematic the field is when it announced that...
StreetInsider.com  Apr 17  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Idera+%28IDRA%29+Initiates+TLR+Inhibitor+IMO-3100+Phase+2/7349137.html for the full story.
StreetInsider.com  Oct 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Dynavax+%28DVAX%29+Expands+TLR+Inhibitor+Alliance+with+Glaxo+%28GSK%29%3B+Will+Receive+%243M+Milestone/6873809.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki